Company / PP&E per Share
Vaxcyte, Inc. PP&E per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$1.89
FY2025
5-year range
$0.15 / $1.89
FY2021-FY2025
Trend
+16.5%
vs FY2024
Sector context
#37 of 191
Health Care
What the data says
Vaxcyte, Inc.'s pp&e per share of $1.89 is higher than 81% of companies in the Health Care sector (FY2025). PP&E per Share has increased for 5 consecutive years, from $0.11 in FY2020 to $1.89 in FY2025.
Based on SEC 10-K filings.
1.89 in FY2025 with a 5-year CAGR of +76.4%. Top quartile in the Health Care sector.
Improved from $0.82 to $1.89 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +127.9%
- 5-Year CAGR
- +76.4%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 191This company $1.89 Sector average $22.34
▼
-91.5% below sector average
Key checks
Key Insights
- Vaxcyte, Inc.'s pp&e per share has grown for 5 consecutive years.
- In FY2025, pp&e per share increased 16.5% year-over-year.
- Ranks #37 out of 191 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.89 | +16.5% |
| FY2024 | $1.62 | +98.1% |
| FY2023 | $0.82 | +413.2% |
| FY2022 | $0.16 | +4.2% |
| FY2021 | $0.15 | +38.3% |
| FY2020 | $0.11 | -87.6% |
| FY2019 | $0.89 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026